Convergent Therapeutics – Next Generation Radiopharmaceutical Therapies for Cancer
Philip Kantoff, Co-founder and CEO of Convergent Therapeutics, a clinical-stage pharmaceutical company focused on developing next-generation radiopharma...
263 articles
Philip Kantoff, Co-founder and CEO of Convergent Therapeutics, a clinical-stage pharmaceutical company focused on developing next-generation radiopharma...
Scott Rombach, CEO of Specialist Direct discusses how telepathology and telehealth can make all the difference by enabling the faster evaluation of dona...
Neurosurgeon, Dr.Theresa Williamson talks about her presentation on Simplifying Surgery: Augmented Reality in Complex Spinal Procedures, which addresses...
David Hanscom, MD, an orthopedic complex spinal deformity surgeon discusses his new book "Do You Really Need Spine Surgery?" He is the author of the ...
Kathy Sapp, CEO of The American Chronic Pain Association, a philanthropic organization, and Dr. Learn more on Health Professional Radio.
Rakesh Jain, Clinical Professor, Department of Psychiatry, Texas Tech School of Medicine, Austin, TX discusses tardive dyskinesia or TD, a chronic condi...
Robert Hummel, Chief Operating Officer at Suvoda, a global clinical trial technology company, discusses the rise in trial complexity, how the focus has ...
Medical Lead, Rare Disease at UCB discusses the positive topline results from the Phase 3 RAISE trial evaluating zilucoplan, a self-administered, subcut...
Thomas Lendvay, CMO and co-founder of Tend Health, Inc. Learn more on Health Professional Radio.
Bill Stilley, is CEO and President of Adial Pharma, a company focused on developing therapies for the treatment of addiction and related diseases, speci...